{"status":"OK","data":{"advertisement":{"id":226615,"title":"Opracowanie bifunkcjonalnego przeciwcia\u0142a fuzyjnego do innowacyjnej immunoterapii celuj\u0105cej w receptor chemokinowy do leczenia przerzutowego raka nerkowokom\u00f3rkowego.","partial_offer_allowed":false,"publication_date":"2023-09-11","submission_deadline":"2023-10-11 23:59:59","planned_sign_date":"2023-10-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-10-12 00:00:03","contact_persons":[{"id":5204,"forename":"Dorota ","surname":"Trznadel","phone_number":"790870001","email":"d.trznadel@purebiologics.com","created_by":null,"created_at":"2023-03-28 22:37:24","modified_at":"2023-03-28 22:37:24","modified_by":null}],"orders":[{"id":370748,"estimated_value":null,"order_items":[{"id":419051,"description":"Przedmiotem zam\u00f3wienia jest us\u0142uga polegaj\u0105ca na przeprowadzeniu badania klinicznego \nfazy 0 obejmuj\u0105cego donowotworowe podanie pacjentom cz\u0105steczek terapeutycznych opracowanych \nw ramach projektu PB105/PureMax u pacjent\u00f3w z nowotworami g\u0142owy i szyi, zgodnie ze szczeg\u00f3\u0142owym opisem zawartym w za\u0142\u0105czniku nr 2. //The subject of the contract is a service consisting of conducting a Phase 0 clinical trial of therapeutic molecules developed by the PB105/PureMax project for the intratumoral administrations of head and neck cancer patients in accordance with the detailed description in attachment no 2. \n","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-09-11 13:18:19","modified_by":null,"id":470519,"type":{"id":1,"name":"adres"},"group_uuid":"b6829126-6798-4e0a-83f1-e0bbd197ec2d"}],"participation_conditions":[{"id":1143898,"description":"Z post\u0119powania o udzielenie zam\u00f3wienia wykluczeniu podlegaj\u0105 Oferenci, kt\u00f3rzy s\u0105 powi\u0105zani osobowo lub kapita\u0142owo z Zamawiaj\u0105cym. Przez powi\u0105zania kapita\u0142owe lub osobowe rozumie si\u0119 wzajemne powi\u0105zania mi\u0119dzy Zamawiaj\u0105cym lub osobami upowa\u017cnionymi do zaci\u0105gania zobowi\u0105za\u0144 w imieniu Zamawiaj\u0105cego lub osobami wykonuj\u0105cymi w imieniu Zamawiaj\u0105cego czynno\u015bci zwi\u0105zane z przygotowaniem i przeprowadzeniem procedury wyboru Wykonawcy a Oferentem, polegaj\u0105ce w szczeg\u00f3lno\u015bci na: \na)\tuczestniczeniu w sp\u00f3\u0142ce jako wsp\u00f3lnik sp\u00f3\u0142ki cywilnej lub sp\u00f3\u0142ki osobowej,\nb)\tposiadaniu co najmniej 10% udzia\u0142\u00f3w lub akcji,\nc)\t pe\u0142nieniu funkcji cz\u0142onka organu nadzorczego lub zarz\u0105dzaj\u0105cego, prokurenta, pe\u0142nomocnika,\nd)\tpozostawaniu w zwi\u0105zku ma\u0142\u017ce\u0144skim, w stosunku pokrewie\u0144stwa lub powinowactwa\nw linii prostej, pokrewie\u0144stwa drugiego stopnia lub powinowactwa drugiego stopnia\nw linii bocznej lub w stosunku przysposobienia, opieki lub kurateli.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-09-11 13:18:19","modified_by":null,"group_uuid":"70f1406c-cc89-44aa-accd-f8cdc4a4af11"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-09-11 13:18:19","modified_by":null,"group_uuid":"7a2e0e1f-24ad-4d09-b225-acf6d7f11700"}],"evaluation_criteria":[{"id":638419,"price_criterion":true,"description":"Ilo\u015b\u0107 punkt\u00f3w zost. oblicz. w/g poni\u017cszego wzoru (licz\u0105c do dw\u00f3ch miejsc po przecinku):\n\n Ilo\u015b\u0107 punkt\u00f3w= (C min / C oferty) * 100 pkt\nGdzie:\nC min - najni\u017csza cena ze wszystkich z\u0142o\u017conych ofert \nC oferty - cena badanej oferty","created_by":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-09-11 13:18:19","modified_by":null,"group_uuid":"de00a54d-1c18-4503-a301-d88973615f5c"}],"is_variant":false,"title":"Badanie kliniczne fazy 0 ","order_node":{"id":281733},"created_by":null,"created_at":"2023-09-11 13:18:19","modified_at":"2023-09-11 13:18:19","modified_by":null}],"created_by":{"id":5901,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Pure Biologics S.A.","identification_number_type":"nip","identification_number":"8943003192","address":{"country":"Polska","voivodeship":"dolno\u015bl\u0105skie","poviat":"Wroc\u0142aw","commune":"Wroc\u0142aw-Fabryczna","locality":"Wroc\u0142aw","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":595613,"street":"Du\u0144ska","number_description":"11","postcode":"54-427"},"created_by":{"id":5901,"contact_persons":[]},"created_at":"2023-09-11 13:18:18","modified_at":"2023-09-11 13:18:18","modified_by":{"id":5901,"contact_persons":[]},"id":227112},"advertisement":{"id":172680,"number":"2023-5901-172680","publication_date":"2023-09-11","created_by":{"id":5901,"contact_persons":[]},"created_at":"2023-09-11 13:18:18","modified_at":"2023-10-12 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[226615],"enrollment":{"id":41041,"name":"-","number":"002/23","activity":{"created_by":null,"created_at":"2023-02-01 09:22:25","modified_at":"2023-02-01 09:22:25","modified_by":null},"region":null,"institution":{"created_by":null,"created_at":"2023-02-01 09:28:01","modified_at":"2023-02-01 09:28:01","modified_by":null},"full_number":"FENG.01.01-IP.02-002/23","perspective":{},"programme":{"created_by":null,"created_at":"2023-02-01 09:21:41","modified_at":"2023-02-01 09:21:41","modified_by":null},"priority":{"created_by":null,"created_at":"2023-02-01 09:21:51","modified_at":"2023-02-01 09:21:51","modified_by":null},"type":"enrollment","created_by":null,"created_at":"2023-09-11 12:47:04","modified_at":"2023-09-11 12:47:04","modified_by":null},"projects":[],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127262,"name":"PB105/PureMax/2023/03- Zapytanie ofertowe wraz z Za\u0142.nr 1 i 3","file":{"id":1256354,"name":"PB105_PureMax_2023_03- Zap. of. wraz z Za\u0142.nr 1 i 3.pdf","created_at":"2023-09-11 13:02:43","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256354"},"group_uuid":"1e211ffc-47ef-46b3-894b-5f5b655e67b0"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127263,"name":"PB105/PureMax/2023/03- Za\u0142\u0105cznik nr 2 Szczeg\u00f3\u0142owy opis us\u0142ugi","file":{"id":1256360,"name":"PB105_PureMax_2023_03- Za\u0142\u0105cznik nr 2 Szczeg\u00f3\u0142owy opis us\u0142ugi_Faza 0.pdf","created_at":"2023-09-11 13:03:58","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256360"},"group_uuid":"097e3d6d-24e5-4622-9f0d-e84bce365106"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127264,"name":"PB105/PureMax/2023/03-Za\u0142.1- Formularz Oferty. edytowalny","file":{"id":1256382,"name":"PB105_PureMax_2023_03-Za\u0142.1- Formularz Oferty.docx","created_at":"2023-09-11 13:06:23","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256382"},"group_uuid":"62f144f0-18c1-46ef-b4e4-4e6d694fae45"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127265,"name":"PB105/PureMax/2023/03-Za\u0142. 3- O\u015bwiadczenie- edytowalne","file":{"id":1256396,"name":"PB105_PureMax_2023_03-Za\u0142. 3- O\u015bwiadczenie.docx","created_at":"2023-09-11 13:07:17","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256396"},"group_uuid":"348a516d-ba8a-4d22-8a55-d12c60ce0426"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127266,"name":"PB105/PureMax/2023/03- Request with Att. 1 & 3","file":{"id":1256400,"name":"PB105_PureMax_2023_03- Request, Att. 1 & 3.pdf","created_at":"2023-09-11 13:08:19","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256400"},"group_uuid":"5ff2b0a9-160c-4857-ad43-ca106af8f0f0"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127267,"name":"PB105/PureMax/2023/03-Detailed description","file":{"id":1256404,"name":"PB105_PureMax_2023_03-Detailed descrio._Att. no 2.pdf","created_at":"2023-09-11 13:09:33","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256404"},"group_uuid":"0c1095fb-0ffe-4911-a84e-82a391f599ea"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127268,"name":"PB105/PureMax/2023/03-Att. 1- Offer Form, editable","file":{"id":1256410,"name":"PB105_PureMax_2023_03-Att. 1- Offer Form.docx","created_at":"2023-09-11 13:10:52","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256410"},"group_uuid":"e777c2ce-a03e-4835-bd2f-e8cd2aa08226"},{"origin":{"id":226615,"publication_date":"2023-09-11"},"id":1127269,"name":"PB105/PureMax/2023/03- Att. 3- Declaration of lack..- editable","file":{"id":1256416,"name":"PB105_PureMax_2023_03- Att. 3- Deeclaration.docx","created_at":"2023-09-11 13:12:22","created_by":{"forename":"Dorota","surname":"Trznadel"},"uri":"/api/files/1256416"},"group_uuid":"7b80e980-1016-4ed6-850a-87f74df1bbcc"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}